We deliver on your promises

Helping you expedite the development of new medicines, therapies and treatments that advance human health across the globe.

Whether a pharmaceutical, biotech or medical device company, we are your ideal pan-European, full-service CRO.
Our in-depth expertise and long lasting experience combined with a flexible, and collaborative approach allow us to tailor our responses to each individual study.

Our clinical development capabilities span through trial Phases I-IV, across a broad range of therapeutic areas including medical devices.
We have an excellent track record for supporting a range of stakeholders in the pharmaceutical industry including sponsors and research institutions at each clinical development phase.

1500

completed
projects

95

repeat
business

87

positive
recommendation

8

site inspections
from EMA/FDA completed

Tailor-made solutions

Your effective and rigorously compliant project strategy will be tailor-made to the specific requirements of your clinical trial. Our flexibility in project design and implementation, based on our in hours expertise and experience is backed up by delivering full-service with deep local expertise across Europe.

Your Regulatory and Operational Local Expert

You gain access to a population of more than 500 million people throughout our 24 offices in strategic locations in Europe. Currently, we’re running more than 300 active trials in 36 different countries.

Delivery focused

A proud track record of accelerated start-up timelines, over-achievement of recruitment targets, early completions and cost competitive budgetary adherence demonstrates that we are extremely focused at running efficient and effective clinical trials.

Shared goals

You need a CRO partner who is as invested in the success of each bespoke clinical trial as you are. We collaborate closely, constantly making sure that we are aligned with your study expectations and key study milestones. Essentially, we become an extended arm to your team with the same shared goals.

Pharmaceutical companies
Delivery-focused bespoke solutions for all phases of drug development.
Biotechnology enterprises
Dedicated service and expertise that delivers high-quality, cost-effective results.
Medical Device companies
Smart solutions built on a combination of regulatory expertise and deep understanding of project specificities.

News

October 28, 2022 in News

Optimapharm Further Expands in the US to Enhance Customer Collaboration

Optimapharm Further Expands in the US to Enhance Customer Collaboration We Deliver on Your Promises In line with its strategic growth plans, Optimapharm has opened a new office in Boston, Massachusetts this September. The role of this office will be…
Read More
October 3, 2022 in News

Optimapharm announces EUCROF webinar presentation

Person-Centric Clinical Trials - Webinar Optimapharm announces Ana Stojković as a speaker at the EUCROF webinar - Person-Centric Clinical Trials.  Optimapharm is delighted to share that our VP of Clinical Operations - Ana Stojković, will be one of the speakers…
Read More
September 28, 2022 in News

Optimapharm Conference Attendance in Q3 & Q4 of 2022

Optimapharm Announces Conferences Attendance in Q4 of 2022 Optimapharm d.o.o. (“Optimapharm”), a leading European, mid-sized, full-service Clinical Research Organization (CRO), is pleased to announce its attendance at conferences in Q4 of 2022. BIO EUROPE 2022 BIO-Europe has a long track…
Read More
June 27, 2022 in News

Optimapharm Announces Acquisition of Qualitis SA

Optimapharm Announces Acquisition of Qualitis SA We Deliver on Your Promises Optimapharm d.o.o. (“Optimapharm”), a leading European, mid-sized, full-service Clinical Research Organization (CRO), is pleased to announce the acquisition of Qualitis SA (“Qualitis”). This acquisition will complement Optimapharm’s geographic coverage…
Read More